Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05283)

• Formulation Name: Deferiprone 500 mg tablet
• Company: ApoPharma USA

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Deferiprone	(DMS2M7O)	Beta thalassemia	3A50.2	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent